Wed, 12th May 2021 07:33
LONDON, May 12 (Reuters) - Private equity firm Clayton,
Dubilier & Rice (CDR) has agreed to buy London-listed UDG
Healthcare for 2.6 billion pounds ($3.7 billion), the
pharmaceuticals services company said on Wednesday.
CDR has agreed to pay 10.23 pounds in cash per share in UDG,
a premium of 21.5% on Tuesday's close.
($1 = 0.7076 pounds)
(Editing by Keith Weir and Jason Neely)
IN BRIEF: UDG Healthcare acquisition by CD&R completes
TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE
UDG Healthcare takeover okayed by court but puts short stay on scheme
(Sharecast News) - Wizz Air: HSBC downgrades to 'reduce' and lowers target price from 4,500.0p to 4,100.0p; JP Morgan keeps at 'overweight' and marks ...
BROKER RATINGS: Citi resumes Melrose at Buy; Peel cuts Pets At Home
